Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application

Background: Multiple sclerosis (MS) afflicts more than 2.5 million individuals worldwide and this number is increasing over time. Within the past years, a great number of disease-modifying treatments have emerged; however, efficacious treatments and a cure for MS await discovery. Thymosins, soluble...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Mult Scler Relat Disord
Glavni autori: Severa, Martina, Zhang, Jing, Giacomini, Elena, Rizzo, Fabiana, Etna, Marilena Paola, Cruciani, Melania, Garaci, Enrico, Chopp, Michael, Coccia, Eliana Marina
Format: Artigo
Jezik:Inglês
Izdano: Elsevier B.V. 2019
Teme:
Review article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7104151/
https://ncbi.nlm.nih.gov/pubmed/30317071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2018.09.035
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items